The FTC called out the nation’s leading pharmacy benefit managers for inflating pharmacy costs, affecting both employers and ...
Pharmacy benefit managers overcharged for specialty generic medications — in many cases by hundreds and thousands of percent ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, ...
At a public meeting held on January 15, 2025, the Federal Trade Commission (FTC) summarized the Second Interim Staff Report ...
A yearslong Federal Trade Commission probe, resulting in a report released in July, reported that of the six pharmacy benefit ...
Pharmacy benefit managers are the middlemen in the prescription drug market. The Federal Trade Commission reports the revenue of four PBMs exceeds $1 trillion and they control 86% of the market.
When talking about the influence of pharmacy benefit managers, U.S. Sen. James Lankford exhibits a mastery of how companies like CVS Health control where patients get their medicine, what ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback